Sarepta Therapeutics’ stock falls after patient dies of liver failure

6 months ago 28
ARTICLE AD BOX
The company said that more than 800 people have been treated with Elevidys, with only one experiencing liver failure.
Read Entire Article
  1. Homepage
  2. Finance
  3. Sarepta Therapeutics’ stock falls after patient dies of liver failure

Related

Crypto bulls were amped for potential solana ETF approvals this week. But the government shutdown threw it into limbo.

Crypto bulls were amped for potential solana ETF approvals t...

3 hours ago 2
Morgan Stanley is opening cryptocurrency investments to all clients. Here’s what percentage of your portfolio should be in crypto.

Morgan Stanley is opening cryptocurrency investments to all ...

4 hours ago 2
WIRED Roundup: Are We In An AI Bubble?

WIRED Roundup: Are We In An AI Bubble?

6 hours ago 2

Trending

1. evan peters
2. mariners manager
3. gabe speier
4. chelsea gray
5. gopher hockey
6. clifford lambert palm springs
7. ella langley
8. did ed gein help catch ted bundy
9. blood of my blood season 2
10. las vegas weather

Popular

Can Pidcock win big & why did it end at Ineos?

Can Pidcock win big & why did it end at Ineos?

7 months ago 326
Netflix scuttles plans to add six previously announced games to its service

Netflix scuttles plans to add six previously announced games...

8 months ago 315
OpenAI co-founder John Schulman has left Anthropic after less than a year

OpenAI co-founder John Schulman has left Anthropic after les...

8 months ago 275
Steam will label early access games that haven't been updated in a year

Steam will label early access games that haven't been update...

8 months ago 275
‘I didn’t want to spend time with my children. I was just going through the motions’: the pain of parental burnout

‘I didn’t want to spend time with my children. I was just go...

7 months ago 271
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Nexa News 2025. All rights are reserved